Pentoxifylline D6
| Product Name | Pentoxifylline D6 |
|---|---|
| Alternate Names | Pentoxifylline Stable Isotopes, Stable Isotopes of Pentoxifylline |
| CAT No. | CS-T-60258 |
| CAS No. | 1185878-98-1 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 284.34 g/mol |
| Mol. For. | C₁₃H₁₂D₆N₄O₃ |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Pentoxifylline |
| Smileys | CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C |
| Canonical Smiles | CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C |
| InchIKey | BYPFEZZEUUWMEJ-XERRXZQWSA-N |
| Inchl | InChI=1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3/i2D3,3D3 |
| IUPAC | 1-(5-oxohexyl)-3,7-bis(trideuteriomethyl)purine-2,6-dione |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Pentoxifylline D6 is a deuterated derivative of the drug Pentoxifylline, which is used in the treatment of peripheral vascular disease and related conditions. It is a xanthine derivative that improves blood circulation by decreasing the viscosity of blood, which in turn increases the oxygen supply to tissues. Pentoxifylline D6 is used as a tracer in pharmacokinetic studies, as it is easily detectable through mass spectrometry.
The chemical formula of Pentoxifylline D6 is C13D6H18N4O3, and its molecular weight is 260.34 g/mol. It is a white crystalline powder that is soluble in water and ethanol. Its melting point is 105-107°C, and it has a purity of 99%.
Pentoxifylline D6 is administered orally, either in tablet or capsule form. The recommended dosage for adult patients is 400 mg, taken three times daily. It is important to follow the prescribed dosage and duration of treatment to avoid any adverse effects.
Pentoxifylline D6 is generally well-tolerated, but some patients may experience side effects such as nausea, vomiting, abdominal discomfort, headache, and dizziness. It is contraindicated in patients with a history of bleeding disorders or recent hemorrhage, as it can increase the risk of bleeding. It should also be used with caution in patients with liver or kidney impairment.
In conclusion, Pentoxifylline D6 is a useful tool in pharmacokinetic studies and is an effective treatment option for peripheral vascular disease. However, it should only be used under the guidance of a healthcare professional and with careful consideration of potential risks and benefits.
Get an Instant Quote
Related Compounds
Pentoxifylline-d3 | Pentoxifylline D5 | Hydroxy Pentoxifylline D5 | Hydroxy Pentoxifylline-d3 | Hydroxy Pentoxifylline D4 |